IMS Company Profiles - Report Buyer
IMS Company Profiles - Report Buyer IMS Company Profiles - Report Buyer
IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING BENZETACIL LA (pen i cil lin me dium/nar row spec - trum) CURAM (pen i cil lin broad spec trum) PEN-VEE K (pen i cil lin me dium/nar row spec trum) SERVAMOX (pen i cil lin broad spec trum) TAMSULOSINA (BPH (be nign pros tatic hy per tro - phy) prod uct) Ther a peu tic Range: antibacterials sys temic 67% urologicals 8% an ti bi ot ics, sulphonamides and antivirals top i cal 6% musculoskeletal drugs other 5% renin-an gio ten sin sys tem agents 4% Lead ing Dose Forms: tab lets 24% vi als 21% liq uids 17% cap sules 15% coated tab lets 13% CROATIA LEK Full Name: Lek Zagreb d.o.o. Street Ad dress: 10000 Zagreb, Maksimirska 120 Tel: +385 1 2353 111 Fax: +385 1 2337 785 Con tacts (Pharm): Chair man: Alojz Pungarsek; Gen eral Con tact: Alojz Pungarsek Sub sid iary of: Novartis, Swit zer land (100%) Phar ma ceu ti cal Sales: US$ 40-45 mil lion Prod ucts (% of Sales by Lead ing 5): 45-50% Ther a peu tic Classes (% of Sales by Lead ing 5): 50-55% Dose Forms (% of Sales by Lead ing 5): 90-95% Prin ci pal Prod ucts: AMLOPIN (cal cium an tag o nist plain) TU LIP (cho les terol/triglyceride reg u lat ing prep a - ra tion) SANVAL (hyp notic/sed a tive) OPERIL (na sal prep a ra tion top i cal) LEKADOL (an al ge sic non-nar cotic) Ther a peu tic Range: cal cium an tag o nists 17% lipid-reg u lat ing/antiatheroma prep a ra tions 13% psycholeptics 9% na sal prep a ra tions 8% an al ge sics 7% Lead ing Dose Forms: tab lets 44% coated tab lets 28% cap sules 10% liq uids 7% pres sur ised aero sols 5% NOVARTIS Full Name: Novartis Pharma d.o.o. Street Ad dress: 10000 Zagreb, Zaharova 7b, 2nd Floor Tel: +385 1 6274 220 Fax: +385 1 6274 255 Con tacts (Pharm): Gen eral Con tact: Denis Vujicic Phar ma ceu ti cal Sales: US$ 16-18 mil lion Prod ucts (% of Sales by Lead ing 5): 70-75% Ther a peu tic Classes (% of Sales by Lead ing 5): 80-85% Dose Forms (% of Sales by Lead ing 5): 95-100% Prin ci pal Prod ucts: LESCOL (cho les terol/triglyceride reg u lat ing prep - a ra tion) LEPONEX (antipsychotic) CO-DIOVAN (an gio ten sin-II an tag o nist com bi na - tion) DIOVAN (an gio ten sin-II an tag o nist plain) SANDIMMUN NEORAL (immunosuppressive agent) Ther a peu tic Range: renin-an gio ten sin sys tem agents 24% lipid-reg u lat ing/antiatheroma prep a ra tions 22% psycholeptics 14% immunosuppressive agents 12% cytostatic hor mone ther apy 11% Lead ing Dose Forms: cap sules 44% coated tab lets 32% tab lets 20% liq uids 2% med i cal dress ings 2% CZECH REPUBLIC CHIRON Street Ad dress: Hviezdoslavova, 627 00 Brno Tel: +420 5 48213610 Fax: +420 5 48213611 Email: info@chironvaccines.com © 2009 IMS Health In cor po rated or its af fil i ates Page 160
IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING LEK Full Name: Lek Pharma s. r. o. Street Ad dress: Jeseniova 30, 130 00 Praha 3 Tel: +420 2 21421611/21421613 Fax: +420 2 21421629/21421630 Email: lekcz@lekpharma.anet.cz De scrip tion: Rep re sen ta tive of fice. Con tacts (Pharm): Chair man: Joze Kavticnik; Gen eral Con tact: Joze Kavticnik NOVARTIS Full Name: Novartis s.r.o. Street Ad dress: Nagano III., U Nakladoveho nadrazi 10, 130 00 Praha Tel: +420 2 25775111 Fax: +420 2 25775222 Home Page: www.novartis.cz De scrip tion: De vel oper, pro moter, sales/detailer. Prod uct ranges in clude: phar ma - ceu ti cal prod ucts (branded, unbranded, pre scrip - tion, non-pre scrip tion), hos pi tal pharmaceuticals, oph thal mic prod ucts, vet er i nary pharmaceuticals. Es tab lished 1996. Di vi sions in clude: Novartis Consumer Health. Con tacts (Pharm): Chair man: Roger Meij; Com mer cial Op er a tions: Pavel Kral; Mar ket Re - search: Lenka Rysava; Gen eral Con tact: Iveta Kotaskova Sub sid iary of: Novartis, Swit zer land (100%) Phar ma ceu ti cal Sales: US$ 95-100 mil lion Prod ucts (% of Sales by Lead ing 5): 50-55% Ther a peu tic Classes (% of Sales by Lead ing 5): 55-60% Dose Forms (% of Sales by Lead ing 5): 95-100% Prin ci pal Prod ucts: GLIVEC (antineoplastic other) FEMARA (cytostatic hor mone an tag o nist) GLYVENOL (var i cose ther apy sys temic) FORADIL (B2-stim u lant) SANDIMMUN NEORAL (immunosuppressive agent) Ther a peu tic Range: antineoplastics 23% cytostatic hor mone ther apy 11% antiasthma and COPD prod ucts 10% antivaricosis/antihemorrhoidal prep a ra tions 9% immunosuppressive agents 6% Lead ing Dose Forms: coated tab lets 46% cap sules 29% tab lets 9% in fu sions 8% liq uids 5% SANDOZ Full Name: Sandoz s.r.o. Street Ad dress: Jeseniova 30, 130 00 Praha 3 Tel: +420 2 21421611 Fax: +420 2 21421629 Sub sid iary of: Novartis, Swit zer land (100%) Phar ma ceu ti cal Sales: US$ 75-80 mil lion Prod ucts (% of Sales by Lead ing 5): 40-45% Ther a peu tic Classes (% of Sales by Lead ing 5): 60-65% Dose Forms (% of Sales by Lead ing 5): 95-100% Prin ci pal Prod ucts: AMOKSIKLAV (pen i cil lin broad spec trum) TU LIP (cho les terol/triglyceride reg u lat ing prep a - ra tion) GINGIO (ce re bral/pe riph eral vasotherapeutic) ACC LONG (ex pec to rant) PIRAMIL (ACE in hib i tor plain) Ther a peu tic Range: antibacterials sys temic 32% lipid-reg u lat ing/antiatheroma prep a ra tions 10% ce re bral/pe riph eral vasotherapeutics 9% cough and cold prep a ra tions 7% renin-an gio ten sin sys tem agents 6% Lead ing Dose Forms: coated tab lets 39% tab lets 29% vi als 15% cap sules 8% am poules 5% DENMARK HEXAL Full Name: Hexal A/S Street Ad dress: Kanalholmen 8-12, DK-2650 Hvidovre Tel: +45 38 34 42 42 Fax: +45 38 34 11 23 Email: info@hexal.dk Home Page: www.hexal.dk De scrip tion: De vel oper, man u fac turer, ex - porter, dis trib u tor, sales/detailer. Pro motes, sells/de tails for other com pa nies. Prod uct ranges in clude: phar ma ceu ti cal prod ucts (non-pre scrip - © 2009 IMS Health In cor po rated or its af fil i ates Page 161
- Page 109 and 110: IMS COM PANY PRO FILES NOVARTIS Sal
- Page 111 and 112: IMS COM PANY PRO FILES NOVARTIS Sal
- Page 113 and 114: IMS COM PANY PRO FILES NOVARTIS COW
- Page 115 and 116: IMS COM PANY PRO FILES NOVARTIS Met
- Page 117 and 118: IMS COM PANY PRO FILES NOVARTIS Oth
- Page 119 and 120: IMS COM PANY PRO FILES NOVARTIS Pha
- Page 121 and 122: IMS COM PANY PRO FILES NOVARTIS Thi
- Page 123 and 124: IMS COM PANY PRO FILES NOVARTIS Emp
- Page 125 and 126: IMS COM PANY PRO FILES NOVARTIS Pro
- Page 127 and 128: IMS COM PANY PRO FILES NOVARTIS Pro
- Page 129 and 130: IMS COM PANY PRO FILES NOVARTIS Pro
- Page 131 and 132: IMS COM PANY PRO FILES NOVARTIS Com
- Page 133 and 134: IMS COM PANY PRO FILES NOVARTIS Com
- Page 135 and 136: IMS COM PANY PRO FILES NOVARTIS Com
- Page 137 and 138: IMS COM PANY PRO FILES NOVARTIS Com
- Page 139 and 140: IMS COM PANY PRO FILES NOVARTIS Nov
- Page 141 and 142: IMS COM PANY PRO FILES NOVARTIS San
- Page 143 and 144: IMS COM PANY PRO FILES NOVARTIS als
- Page 145 and 146: IMS COM PANY PRO FILES NOVARTIS Nov
- Page 147 and 148: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 149 and 150: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 151 and 152: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 153 and 154: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 155 and 156: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 157 and 158: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 159: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 163 and 164: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 165 and 166: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 167 and 168: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 169 and 170: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 171 and 172: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 173 and 174: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 175 and 176: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 177 and 178: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 179 and 180: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 181 and 182: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 183 and 184: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 185 and 186: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 187 and 188: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 189 and 190: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 191 and 192: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 193 and 194: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 195 and 196: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 197 and 198: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 199 and 200: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 201 and 202: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 203 and 204: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 205 and 206: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 207 and 208: IMS COM PANY PRO FILES NOVARTIS SUB
- Page 209 and 210: IMS COM PANY PRO FILES NOVARTIS SUB
<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />
BENZETACIL LA (pen i cil lin me dium/nar row spec -<br />
trum)<br />
CURAM (pen i cil lin broad spec trum)<br />
PEN-VEE K (pen i cil lin me dium/nar row spec trum)<br />
SERVAMOX (pen i cil lin broad spec trum)<br />
TAMSULOSINA (BPH (be nign pros tatic hy per tro -<br />
phy) prod uct)<br />
Ther a peu tic Range:<br />
antibacterials sys temic 67%<br />
urologicals 8%<br />
an ti bi ot ics, sulphonamides and antivirals top i cal<br />
6%<br />
musculoskeletal drugs other 5%<br />
renin-an gio ten sin sys tem agents 4%<br />
Lead ing Dose Forms:<br />
tab lets 24%<br />
vi als 21%<br />
liq uids 17%<br />
cap sules 15%<br />
coated tab lets 13%<br />
CROATIA<br />
LEK<br />
Full Name: Lek Zagreb d.o.o.<br />
Street Ad dress: 10000 Zagreb, Maksimirska<br />
120<br />
Tel: +385 1 2353 111<br />
Fax: +385 1 2337 785<br />
Con tacts (Pharm): Chair man: Alojz Pungarsek;<br />
Gen eral Con tact: Alojz Pungarsek<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
Phar ma ceu ti cal Sales: US$ 40-45 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 45-50%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 50-55%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
90-95%<br />
Prin ci pal Prod ucts:<br />
AMLOPIN (cal cium an tag o nist plain)<br />
TU LIP (cho les terol/triglyceride reg u lat ing prep a -<br />
ra tion)<br />
SANVAL (hyp notic/sed a tive)<br />
OPERIL (na sal prep a ra tion top i cal)<br />
LEKADOL (an al ge sic non-nar cotic)<br />
Ther a peu tic Range:<br />
cal cium an tag o nists 17%<br />
lipid-reg u lat ing/antiatheroma prep a ra tions<br />
13%<br />
psycholeptics 9%<br />
na sal prep a ra tions 8%<br />
an al ge sics 7%<br />
Lead ing Dose Forms:<br />
tab lets 44%<br />
coated tab lets 28%<br />
cap sules 10%<br />
liq uids 7%<br />
pres sur ised aero sols 5%<br />
NOVARTIS<br />
Full Name: Novartis Pharma d.o.o.<br />
Street Ad dress: 10000 Zagreb, Zaharova 7b,<br />
2nd Floor<br />
Tel: +385 1 6274 220<br />
Fax: +385 1 6274 255<br />
Con tacts (Pharm): Gen eral Con tact: Denis<br />
Vujicic<br />
Phar ma ceu ti cal Sales: US$ 16-18 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 70-75%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 80-85%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
95-100%<br />
Prin ci pal Prod ucts:<br />
LESCOL (cho les terol/triglyceride reg u lat ing prep -<br />
a ra tion)<br />
LEPONEX (antipsychotic)<br />
CO-DIOVAN (an gio ten sin-II an tag o nist com bi na -<br />
tion)<br />
DIOVAN (an gio ten sin-II an tag o nist plain)<br />
SANDIMMUN NEORAL (immunosuppressive<br />
agent)<br />
Ther a peu tic Range:<br />
renin-an gio ten sin sys tem agents 24%<br />
lipid-reg u lat ing/antiatheroma prep a ra tions<br />
22%<br />
psycholeptics 14%<br />
immunosuppressive agents 12%<br />
cytostatic hor mone ther apy 11%<br />
Lead ing Dose Forms:<br />
cap sules 44%<br />
coated tab lets 32%<br />
tab lets 20%<br />
liq uids 2%<br />
med i cal dress ings 2%<br />
CZECH REPUBLIC<br />
CHIRON<br />
Street Ad dress: Hviezdoslavova, 627 00 Brno<br />
Tel: +420 5 48213610<br />
Fax: +420 5 48213611<br />
Email: info@chironvaccines.com<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 160